| Dr Katherine Denise Percy, DO | |
|
1 Jarrett White Road, Tripler Army Medical Center, 1 Jarrett White Road, HI 96859-5095 | |
| (808) 433-2778 | |
| (808) 433-4982 |
| Full Name | Dr Katherine Denise Percy |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | 1 Jarrett White Road, 1 Jarrett White Road, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073958914 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | DOS-1765 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Straub Clinic And Hospital | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Straub Clinic And Hospital | 6305759754 | 404 |
| Waianae District Comprehensive Health And Hospital Board, Incorporated | 9931008349 | 113 |
News Archive
Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19). This disease currently has no approved treatment.
GeNeuro announced today that its GNbAC1 humanized monoclonal antibody was found to have a very good safety profile when administered to patients with relapsing and progressive forms of Multiple Sclerosis as part of a Phase 2a study.
A team of researchers at the Wake Forest Baptist Medical Center found that information found on the internet can serve as good means to diagnose individuals who suspect they have a rare disorder that has not been identified by their doctors.
For nearly two decades, the medical world and the American public have grappled with the lightning-rod topic of stem cells, in particular the controversy surrounding cells from human embryos. But when researchers four years ago successfully "reprogrammed" adult body cells to become stem cells, some thought the ethical debate was nearly over. Those redirected cells, known as induced pluripotent cells, or iPS cells, show potential as therapy.
A new program may help overcome common barriers to finding living kidney donors. The program will be highlighted at ASN Kidney Week 2016 November 15¬-20 at McCormick Place in Chicago, IL.
› Verified 2 days ago
| Entity Name | Straub Clinic & Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306508 PECOS PAC ID: 6305759754 Enrollment ID: O20031111000417 |
News Archive
Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19). This disease currently has no approved treatment.
GeNeuro announced today that its GNbAC1 humanized monoclonal antibody was found to have a very good safety profile when administered to patients with relapsing and progressive forms of Multiple Sclerosis as part of a Phase 2a study.
A team of researchers at the Wake Forest Baptist Medical Center found that information found on the internet can serve as good means to diagnose individuals who suspect they have a rare disorder that has not been identified by their doctors.
For nearly two decades, the medical world and the American public have grappled with the lightning-rod topic of stem cells, in particular the controversy surrounding cells from human embryos. But when researchers four years ago successfully "reprogrammed" adult body cells to become stem cells, some thought the ethical debate was nearly over. Those redirected cells, known as induced pluripotent cells, or iPS cells, show potential as therapy.
A new program may help overcome common barriers to finding living kidney donors. The program will be highlighted at ASN Kidney Week 2016 November 15¬-20 at McCormick Place in Chicago, IL.
› Verified 2 days ago
| Entity Name | Waianae District Comprehensive Health And Hospital Board, Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275566424 PECOS PAC ID: 9931008349 Enrollment ID: O20040105000833 |
News Archive
Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19). This disease currently has no approved treatment.
GeNeuro announced today that its GNbAC1 humanized monoclonal antibody was found to have a very good safety profile when administered to patients with relapsing and progressive forms of Multiple Sclerosis as part of a Phase 2a study.
A team of researchers at the Wake Forest Baptist Medical Center found that information found on the internet can serve as good means to diagnose individuals who suspect they have a rare disorder that has not been identified by their doctors.
For nearly two decades, the medical world and the American public have grappled with the lightning-rod topic of stem cells, in particular the controversy surrounding cells from human embryos. But when researchers four years ago successfully "reprogrammed" adult body cells to become stem cells, some thought the ethical debate was nearly over. Those redirected cells, known as induced pluripotent cells, or iPS cells, show potential as therapy.
A new program may help overcome common barriers to finding living kidney donors. The program will be highlighted at ASN Kidney Week 2016 November 15¬-20 at McCormick Place in Chicago, IL.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katherine Denise Percy, DO 1 Jarrett White Road, Tripler Army Medical Center, 1 Jarrett White Road, HI 96859-9685 Ph: (808) 433-2778 | Dr Katherine Denise Percy, DO 1 Jarrett White Road, Tripler Army Medical Center, 1 Jarrett White Road, HI 96859-5095 Ph: (808) 433-2778 |
News Archive
Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19). This disease currently has no approved treatment.
GeNeuro announced today that its GNbAC1 humanized monoclonal antibody was found to have a very good safety profile when administered to patients with relapsing and progressive forms of Multiple Sclerosis as part of a Phase 2a study.
A team of researchers at the Wake Forest Baptist Medical Center found that information found on the internet can serve as good means to diagnose individuals who suspect they have a rare disorder that has not been identified by their doctors.
For nearly two decades, the medical world and the American public have grappled with the lightning-rod topic of stem cells, in particular the controversy surrounding cells from human embryos. But when researchers four years ago successfully "reprogrammed" adult body cells to become stem cells, some thought the ethical debate was nearly over. Those redirected cells, known as induced pluripotent cells, or iPS cells, show potential as therapy.
A new program may help overcome common barriers to finding living kidney donors. The program will be highlighted at ASN Kidney Week 2016 November 15¬-20 at McCormick Place in Chicago, IL.
› Verified 2 days ago